Peak amplitude and area under the curve of average vertex slow potentials recorded during the foreperiod of a reaction time task were found to discriminate between high- and low-neuroticism subjects, defined according to the Eysenck Personality Inventory. High-neuroticism subjects developed smaller peak amplitude, greater area and longer reaction times, presenting a high extinction rate when the imperative stimulus was omitted. Differences between extraverts and introverts were found within the low-neuroticism group and for area values, extraverts exhibiting larger area. A significant interaction effect of extraversion and neuroticism on slow-potential parameters was evidenced. Results are inter-preted in terms of heightened arousal and disrupted focused attention in high-neuroticism subjects. Although evolutionary indexes of slow potentials could differentiate between extraverts and introverts, further work using inhibition indicators is needed to further clarify the differences between them. The data reported also suggest that different aspects of overt behavior would be associated diversely with slow-potential parameters.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.